Industry
Biotechnology
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
March 21, 2024 | 1:47 pm
Portfolio Pulse from Benzinga Insights
March 21, 2024 | 1:05 pm
Portfolio Pulse from Benzinga Newsdesk
March 20, 2024 | 10:46 am
Portfolio Pulse from Benzinga Newsdesk
March 19, 2024 | 11:08 am
Portfolio Pulse from Benzinga Newsdesk
January 25, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Newsdesk
January 24, 2024 | 9:34 pm
Portfolio Pulse from Benzinga Insights
January 24, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
January 08, 2024 | 5:26 pm
Portfolio Pulse from Avi Kapoor
January 03, 2024 | 3:24 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.